Tag Archives: ExoIntelliScore

Exosome Diagnostics, Inc. announces the publication of positive data from its initial clinical study of ExoIntelliScore™ Prostate

exosome rna

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced the publication of positive data from its initial clinical study of ExoIntelliScore™ Prostate (previously referred to as EXO 106). The first-catch urine-based, three-gene signature liquid biopsy ...

Read More »